4-Methylthiophene-2-boronic acid
Product Information
Molecular Formula
C5H7BO2S
Molecular Weight
141.99
Description
4-Methylthiophene-2-boronic acid is a noteworthy chemical entity utilized extensively in the realm of biomedicine and possesses commendable prospects as a fundamental constituent for synthesizing an array of pharmaceutical agents. Its indispensable participation in formulating therapeutics specifically catered to combat diseases of utmost concern, encompassing cancer, diabetes, and neurological impairments, renders it a paramount catalyst in propelling cutting-edge biomedical exploration and propitious therapeutic breakthroughs.
Synonyms
(4-methylthiophen-2-yl)boronic Acid; 4-methylthiophen-2-ylboronic acid; Boronic acid, (4-methyl-2-thienyl)-; 4-methyl-2-thienylboronic acid; 4-methyl-2-thiopheneboronic acid; 4-Methylthiophene 2-Boronic Acid; (4-Methylthiophen-2-yl)boronicacid; 4-methyl-thiophene-2-boronic acid; 4-Methyl-2-thiophene boronic acid; 4-methylthiophen-2-yl-boronic acid; Boronic acid, B-(4-methyl-2-thienyl)-; 4-methylthiophene-2-boronic acid; 4-Methyl-2-thiopheneboronic Acid (contains varying amounts of Anhydride); 4-methylthiophen-2-ylboronic acid; (4-Methylthiophen-2-yl)boronic acid
IUPAC Name
(4-methylthiophen-2-yl)boronic acid
SMILES
B(C1=CC(=CS1)C)(O)O
InChI
InChI=1S/C5H7BO2S/c1-4-2-5(6(7)8)9-3-4/h2-3,7-8H,1H3
InChI Key
DFUMIZDUIJNUJU-UHFFFAOYAA
Flash Point
Not applicable
Purity
96%
Safety Information
Hazards
H315 - H318 - H335
Precautionary Statement
P280 - P302 + P352 - P305 + P351 + P338 + P310
Computed Properties
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
1
Exact Mass
142.0259808 g/mol
Monoisotopic Mass
142.0259808 g/mol
Topological Polar Surface Area
68.7Ų
Heavy Atom Count
9
Formal Charge
0
Complexity
99
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-114031565-A | N, N' -disubstituted dihydrophenazine-based compound and preparation method and application thereof | 2021-12-09 |
| CN-113845515-A | Aromatic heterocyclic structure-containing dimethyl biphenyl diaryl pyrimidine derivative and preparation method and application thereof | 2021-09-03 |
| AU-2021103877-A4 | Virtual screening method for small molecular reversible inhibitors of flavobacterium alkaline metalloproteinase | 2021-07-05 |
| CN-112679292-A | Synthesis method of secondary sulfonamide compound | 2020-12-25 |
| CN-111303150-A | High-efficiency narrow-half-peak-width aggregation state luminescent material | 2020-03-04 |
| CN-111303150-B | High-efficiency narrow-half-peak-width aggregation state luminescent material | 2020-03-04 |
| WO-2021146255-A1 | Compositions comprising a lipolytic enzyme variant and methods of use thereof | 2020-01-13 |
| WO-2021102569-A1 | Cannabinoid derivatives | 2019-11-26 |
| CN-110577457-A | Copper-catalyzed carboxylation reaction method of arylboronic acid and carbon dioxide | 2019-09-20 |
| CN-110577457-B | Copper-catalyzed carboxylation reaction method of arylboronic acid and carbon dioxide | 2019-09-20 |
